维普中文期刊产品整合服务
22篇 您的检索式:作者名="Stephan Windecker"
    题名 作者 年代 出处 被引量
1Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions显示文摘Donald E. Cutlip Stephan Windecker Roxana Mehran Ashley Boam David J. Cohen Gerrit-Anne van Es P Gabriel Steg Marie-angèle Morel Laura Mauri Pascal Vranckx Eugene McFadden Alexandra Lansky Martial Hamon Mitchell W. Krucoff Patrick W. Serruys 2007Circulation2007,,17:4
2Acute coronary syndromes in young patients: Presentation, treatment and outcome显示文摘Andreas W. Schoenenberger Dragana Radovanovic Jean-Christophe Stauffer Stephan Windecker Philip Urban Gregor Niedermaier Pierre-Frédéric Keller Felix Gutzwiller Paul Erne 2009International Journal of Cardiology2009,,3:2
32-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve Prosthesis显示文摘Lutz Buellesfeld Ulrich Gerckens Gerhard Schuler Raoul Bonan Jan Kovac Patrick W. Serruys Marino Labinaz Peter den Heijer Michael Mullen Wayne Tymchak Stephan Windecker Ralf Mueller Eberhard Grube 2011Journal of the American College of Cardiology2011,,16:1
4Long-Term Propensity Score–Matched Comparison of Percutaneous Closure of Patent Foramen Ovale With Medical Treatment After Paradoxical Embolism显示文摘Andreas Wahl Peter Jüni Marie-Luise Mono Bindu Kalesan Fabien Praz Laura Geister Lorenz R?ber Krassen Nedeltchev Heinrich P. Mattle Stephan Windecker Bernhard Meier 2012Circulation2012,,6:1
52014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS) 显示文摘Stephan Windecker Philippe Kolh Femando Alfonso 2014Eur Heart J2014,35,37:1
6Transient apical ballooning syndrome — clinical characteristics, ballooning pattern, and long-term follow-up in a Swiss population显示文摘Parham Eshtehardi Simon C. Koestner Patrick Adorjan Stephan Windecker Bernhard Meier Otto M. Hess Andreas Wahl Stéphane Cook 2008International Journal of Cardiology2008,,:1
7Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study显示文摘Joost Daemen Peter Wenaweser Keiichi Tsuchida Linda Abrecht Sophia Vaina Cyrill Morger Neville Kukreja Peter Jüni Georgios Sianos Gerrit Hellige Ron T van Domburg Otto M Hess Eric Boersma Bernhard Meier Stephan Windecker Patrick W Serruys 2007The Lancet2007,,9562:1
8Paradoxical Embolism显示文摘Stephan Windecker Stefan Stortecky Bernhard Meier 2014Journal of the American College of Cardiology2014,,4:1
9Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis显示文摘Stéphane Cook Elena Ladich Gaku Nakazawa Parham Eshtehardi Michel Neidhart Rolf Vogel Mario Togni Peter Wenaweser Michael Billinger Christian Seiler Steffen Gay Bernhard Meier Werner J. Pichler Peter Jüni Renu Virmani Stephan Windecker 2009Circulation2009,,:1
10Percutaneous Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism: Long-Term Risk of Recurrent Thromboembolic Events显示文摘Stephan Windecker Andreas Wahl Tushar Chatterjee Ali Garachemani NA R. Eberli Christian Seiler Bernhard Meier 2000Circulation: Journal of the American Heart Association2000,,8:1
11Long-Term Propensity Score–Matched Comparison of Percutaneous Closure of Patent Foramen Ovale With Medical Treatment After Paradoxical Embolism显示文摘Andreas Wahl Peter Jüni Marie-Luise Mono Bindu Kalesan Fabien Praz Laura Geister Lorenz R?ber Krassen Nedeltchev Heinrich P. Mattle Stephan Windecker Bernhard Meier 2012Circulation2012,,6:1
12Long-Term Propensity Score–Matched Comparison of Percutaneous Closure of Patent Foramen Ovale With Medical Treatment After Paradoxical Embolism显示文摘Andreas Wahl Peter Jüni Marie-Luise Mono Bindu Kalesan Fabien Praz Laura Geister Lorenz R?ber Krassen Nedeltchev Heinrich P. Mattle Stephan Windecker Bernhard Meier 2012Circulation2012,,6:1
13Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography显示文摘Andreas Wahl Tony Tai Fabien Praz Markus Schwerzmann Christian Seiler Krassen Nedeltchev Stephan Windecker Heinrich P. Mattle Bernhard Meier 2009JACC: Cardiovascular Interventions2009,,2:1
14Patent Foramen Ovale Screening by Ear Oximetry in Divers显示文摘Michael Billinger Markus Schwerzmann Wilhelm Rutishauser Andreas Wahl Stephan Windecker Bernhard Meier Christian Seiler 2013The American Journal of Cardiology2013,,2:1
152014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)显示文摘Stephan Windecker Philippe Kolh Fernando Alfonso 2014Eur Heart J2014,35,37:1
16Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions显示文摘Donald E. Cutlip Stephan Windecker Roxana Mehran Ashley Boam David J. Cohen Gerrit-Anne van Es P Gabriel Steg Marie-angèle Morel Laura Mauri Pascal Vranckx Eugene McFadden Alexandra Lansky Martial Hamon Mitchell W. Krucoff Patrick W. Serruys 2007Circulation2007,,17:1
17Stable coronary artery disease: revascularisation and invasive strategies显示文摘Raffaele Piccolo Gennaro Giustino Roxana Mehran Stephan Windecker 2015The Lancet . 2015 (9994)2015,,:1
18Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial显示文摘Thomas Pilgrim Dik Heg Marco Roffi David Tüller Olivier Muller André Vuilliomenet Stéphane Cook Daniel Weilenmann Christoph Kaiser Peiman Jamshidi Therese Fahrni Aris Moschovitis Stéphane Noble Franz R Eberli Peter Wenaweser Peter Jüni Stephan Windecker 20142014 (9960)2014,,9960:1
19CODE-EHR:临床研究中运用结构化电子医疗记录的最佳实践框架显示文摘改善患者生存质量是全球临床医学的发展目标,大数据是实现其发展的关键所在。技术进步使结构化电子医疗记录得以常规化,也可能会改善缺失重要临床证据的问题。虽然大数据及其相关分析在新冠大流行期间发挥了重要作用,但也存在严重的缺陷。证实、核验、数据隐私以及对科学研究社会责任的践行是一项重要挑战。欧洲心脏病协会和BigData@Heart联盟已经收集了包括患者代表、临床医生、科研人员、监管机构、期刊编辑和企业代表在内的多元化国际参与者,提出了CODE-EHR的最低标准框架。为改进研究设计、提高信息透明度提供方法手段,同时为实现医疗保健数据的稳健并能够有效运用制定了技术路线图。Dipak Kotecha Folkert W Asselbergs Stephan Achenbach Stefan DAnker Dan Atars Colin Baigent Amitava Banerjee Birgit Beger Cunnar Brobert Barbara Casadei Cinzia Ceccarelli Martin R Cowie Filippo Crea Maureen Cronin Spiros Denaxas Andrea Derix Donna Fitzsimons Martin Fredriksson Chris PGale Georgios V Ckoutos Wim Goettsch Harry Hemingway Martin Ingvaris Adrian Jonas's Robert Kazmierski Susanne Logstrup R Thomas Lumbers Thomas F Lischer Paul McGreavy leana L Pina Lothar Roesiga Carl Steinbeisser Mats Sundgren Benoit Tyl Chislaine van Thiel Kees van Bochove Panos EVardas Tiago Villanueva Marilena Vrana Wim Weber Franz Weidinger Stephan Windecker Angela Wood Diederick E Grobbee 创新药物计划BigData@Heart联盟 欧洲心脏病协会 CODE-EHR国际共识小组 宋奇繁(译) 汪奕名(译) 2022英国医学杂志中文版2022,25,12:0
20Clinical benefit of left atrial appendage closure in octogenarians显示文摘OBJECTIVES Whether left atrial appendage closure(LAAC)in octogenarians yield similar net clinical benefit compared to younger patients,was the purpose of the present study.METHODS Two real-world LAAC registries,enrolling 744 consecutive Amplatzer and Watchman patients from 2009 to 2018,were retrospectively analyzed.RESULTS All events are reported per 100 patient-years.Two hundred and sixty one octogenarians and 483 non-octogenarians with a mean follow-up of 1.7±1.3 and 2.3±1.6 years,and a total of 1,502 patient-years were included.Octogenarians had a higher risk for stroke(CHA2DS2-VASc score:5.2±1.2 vs.4.3±1.7,P<0.0001)and bleeding(HAS-BLED score:3.3±0.8 vs.3.1±1.1,P=0.001).The combined safety endpoint of major periprocedural complications and major bleeding events at follow-up was comparable(30/446,6.7%vs.47/1056,4.4%;hazard ratio[HR]=1.2;95%confidence interval[CI]:0.73−1.98;P=0.48)between the groups.The efficacy endpoint of all-cause stroke,systemic embolism,and cardiovascular/unexplained death occurred more often in octogenarians(61/446,13.7%vs.80/1056,7.6%;HR=7.0;95%CI:4.53−10.93;P<0.0001).Overall,octogenarians had a lower net clinical benefit,i.e.,the composite of all above mentioned hazards,from LAAC compared to younger patients(82/446,18.4%vs.116/1056,11.0%;HR=4.6;95%CI:3.11−7.0;P<0.0001).Compared to the anticipated stroke rate,the observed rate de-creased by 41%in octogenarians and 53%in non-octogenarians.The observed bleeding rate was reduced by 10%octogenarians and 41%non-octogenarians.CONCLUSIONS LAAC can be performed with similar safety in octogenarians as compared to younger patients.On the long-term,it both reduces stroke and bleeding events,although to a lesser extent than in non-octogenarians.Yamen Mohrez Steffen Gloekler Steffen Schnupp Wasim Allakkis Xiao-Xia Liu Monika Fuerholz Johannes Brachmann Stephan Windecker Stephan Achenbach Bernhard Meier Caroline Kleinecke 2021Journal of Geriatric Cardiology2021,18,11:0
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费